Skip to main content

Interface Engineering Will Sell, Service Eksigent's HPLCs in S. Korea

NEW YORK (GenomeWeb News) — Seoul, South Korea-based Interface Engineering will sell and service Eksigent’s NanoLC and ExpressLC high-performance liquid-chromatography systems in Korea, Eksigent said today.
 
Interface Engineering is a division of Bio-Medical Science Co., a group of Korean distribution and life-science technology companies.
 
Financial terms of the agreement were not released.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.